Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations

[1]  G. Lippi,et al.  Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review , 2022, eClinicalMedicine.

[2]  G. Gkoutos,et al.  Symptoms and risk factors for long COVID in non-hospitalized adults , 2022, Nature Medicine.

[3]  C. Steves,et al.  Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies , 2022, European Journal of Epidemiology.

[4]  J. Couzin-Frankel.  Clues to long COVID , 2022, Science.

[5]  J. Danesh,et al.  COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records , 2022, The Lancet Digital Health.

[6]  C. Steves,et al.  Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 , 2022, The Lancet.

[7]  T. Glotzer,et al.  Prospective Evaluation of Autonomic Dysfunction in Post-Acute Sequela of COVID-19 , 2022, Journal of the American College of Cardiology.

[8]  Thomas E. Nichols,et al.  SARS-CoV-2 is associated with changes in brain structure in UK Biobank , 2022, Nature.

[9]  P. Venkatesan.  Do vaccines protect from long COVID? , 2022, The Lancet Respiratory Medicine.

[10]  Shiliang Liu,et al.  Proposed subtypes of post‐COVID‐19 syndrome (or long‐COVID) and their respective potential therapies , 2021, Reviews in medical virology.

[11]  A. L. Tan,et al.  Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. , 2021, The Lancet. Respiratory medicine.

[12]  W. Malorni,et al.  Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy , 2021, European Respiratory Journal.

[13]  David A. Drew,et al.  Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study , 2021, The Lancet Infectious Diseases.

[14]  S. Wiethoff,et al.  Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19 , 2021, Journal of the Neurological Sciences.

[15]  B. Delaney,et al.  Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study , 2021, The British journal of general practice : the journal of the Royal College of General Practitioners.

[16]  T. Spector,et al.  Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study , 2021, The Lancet Digital Health.

[17]  Honghan Wu,et al.  Axes of Prognosis: Identifying Subtypes of COVID-19 Outcomes , 2021, medRxiv.

[18]  Benjamin Bowe,et al.  High-dimensional characterization of post-acute sequelae of COVID-19 , 2021, Nature.

[19]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[20]  Eric Kerfoot,et al.  Accessible data curation and analytics for international-scale citizen science datasets , 2020, Scientific data.

[21]  David A. Drew,et al.  Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app , 2020, Science Advances.

[22]  Tim D. Spector,et al.  Rapid implementation of mobile technology for real-time epidemiology of COVID-19 , 2020, Science.

[23]  Hailin Li,et al.  Multivariate time series clustering based on common principal component analysis , 2019, Neurocomputing.